Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Accumulated Depreciation (2023 - 2025)

Historic Accumulated Depreciation for Cardiff Oncology (CRDF) over the last 8 years, with Q2 2025 value amounting to $4.3 million.

  • Cardiff Oncology's Accumulated Depreciation changed N/A to $4.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.3 million, marking a year-over-year change of. This contributed to the annual value of $4.1 million for FY2024, which is 1026.12% up from last year.
  • Cardiff Oncology's Accumulated Depreciation amounted to $4.3 million in Q2 2025.
  • In the past 5 years, Cardiff Oncology's Accumulated Depreciation registered a high of $4.3 million during Q2 2025, and its lowest value of $3.8 million during Q4 2023.
  • In the last 3 years, Cardiff Oncology's Accumulated Depreciation had a median value of $4.1 million in 2024 and averaged $4.1 million.
  • Examining YoY changes over the last 5 years, Cardiff Oncology's Accumulated Depreciation showed a top increase of 1026.12% in 2024 and a maximum decrease of 1026.12% in 2024.
  • Quarter analysis of 3 years shows Cardiff Oncology's Accumulated Depreciation stood at $3.8 million in 2023, then increased by 10.26% to $4.1 million in 2024, then grew by 4.52% to $4.3 million in 2025.
  • Its Accumulated Depreciation stands at $4.3 million for Q2 2025, versus $4.2 million for Q1 2025 and $4.1 million for Q4 2024.